Vorsitz: S. Kääb (München), J. W. Schrickel (Bonn)
(V145) | Risk factors for atrial fibrillation modulate atrial inward rectifier potassium currents in humans | |
N. Voigt, A. Trausch, A. Friedrich, D. Kirchner, F. Kunze, B. Bollmann, M. Knaut, K. Matschke, U. Ravens, S. Nattel, D. Dobrev (Essen, Dresden; Montreal, CA) | ||
Diskussion | ||
(V146) | Assessment of the association of metabolites and prevalent atrial fibrillation | |
S. Appelbaum, S. S. Johannsen, A. Jagodzinski, K. Khokhlova, N. Rzayeva, S. Blankenberg, R. Schnabel, T. Zeller , DZHK (Hamburg) | ||
Diskussion | ||
(V147) | Cardiac expression and release of micro RNAs into circulation differs between patients with persistent atrial fibrillation and patients with paroxysmal atrial fibrillation | |
B. Niemann, M. Micoogullari, E. Dominik, I. Schweizer, H. Wißbrock, C. Orhan, A. Böning, S. Rohrbach (Gießen) | ||
Diskussion | ||
(V148) | Molecular determinants of altered Na+-Ca2+ exchanger function in patients with chronic atrial fibrillation | |
S. Ghezelbash, C. Espinosa Molina, N. Voigt, J. Heijman, D. Dobrev (Essen) | ||
Diskussion | ||
(V149) | Upregulation of K2P3.1 K+ current causes action potential shortening in patients with chronic atrial fibrillation | |
C. Schmidt, F. Wiedmann, N. Voigt, X. Zhou, J. Heijman, S. Lang, V. Albert, S. Kallenberger, A. Ruhparwar, G. Szabó, K. Kallenbach, M. Karck, M. Borggrefe, P. Biliczki, J. Ehrlich, I. Baczkó, P. Schweizer, B. Donner, H. A. Katus, D. Dobrev, D. Thomas (Heidelberg, Essen, Mannheim, Frankfurt am Main, Wiesbaden, Düsseldorf; Szeged, HU) | ||
Diskussion | ||
(V150) | Autonomic remodeling during atrial fibrillation and diabetes: Do high-frequency atrial heart rhythm and abnormal glucose levels alter cardiac sympathetic tone? | |
C. Gemein, R. Harbst, M. Zink, B. Bellmann, V. Johnson, D. Erkapic, J. Schmitt, C. W. Hamm, P. Schauerte (Gießen, Aachen, Berlin) | ||
Diskussion |